Anno: 2023

Nasus Pharma Announces Publication Of Its Positive Clinical Results With FMXIN002 Intranasal Powder Epinephrine Spray In The Journal Of Allergy And Clinical Immunology In Practice

(Adnkronos) - Rapid and higher epinephrine absorption - for potentially quicker rescue of patients in anaphylactic shock TEL AVIV, Israel, Aug....